class=”sc-29f61514-0 jbwksb”>
Lonza announced Monday that the decision was based on study data showing the effectiveness of a Vertex product to be manufactured here.
Data showed that endogenous insulin (C-peptide) was produced in six patients treated with the product candidate “VX-880”. They also showed improved glycemic control while reducing or eliminating insulin use.
Also, as Lonza explains, patients with a treatment duration greater than 90 days did not experience more severe hypoglycemic events during the evaluation period.
The new manufacturing facility will now be built in Portsmouth, New Hampshire, USA. It will cover an area of approximately 12,000 square meters and will offer up to 300 new jobs at maximum capacity. Construction is scheduled to begin at the end of this year. (SDA)
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
On the same day of the terrorist attack on the Krokus City Hall in Moscow,…
class="sc-cffd1e67-0 iQNQmc">1/4Residents of Tenerife have had enough of noisy and dirty tourists.It's too loud, the…
class="sc-cffd1e67-0 iQNQmc">1/7Packing his things in Munich in the summer: Thomas Tuchel.After just over a year,…
At least seven people have been killed and 57 injured in severe earthquakes in the…
The American space agency NASA would establish a uniform lunar time on behalf of the…
class="sc-cffd1e67-0 iQNQmc">1/8Bode Obwegeser was surprised by the earthquake while he was sleeping. “It was a…